Inicio > Soporte > Referencias

Referencias

Niu, R., Lan, J., Liang, D., Xiang, L., Wu, J., Zhang, X., … Chen, H. (2024). GZMA suppressed GPX4‑mediated ferroptosis to improve intestinal mucosal barrier function in inflammatory bowel disease. Cell Communication and Signaling, 22, 474.

GZMA Suppressed GPX4-mediated Ferroptosis to Improve Intestinal Mucosal Barrier Function in Inflammatory Bowel Disease

Productos recomendados: Recombinant Human GZMA Protein C-His comprado en abinScience
Tao Y, Zhao Y, Wang L, et al. Flexible Amperometric Immunosensor Based on Colloidal Quantum Dots for Detecting the Myeloperoxidase (MPO) Systemic Inflammation Biomarker. Biosensors (Basel). 2023;13(2):255. Published 2023 Feb 10. doi:10.3390/bios13020255

Flexible Amperometric Immunosensor Based on Colloidal Quantum Dots for Detecting the Myeloperoxidase (MPO) Systemic Inflammation Biomarker

Productos recomendados: Recombinant Human MPO Protein N-His comprado en abinScience
Desheva, Y., Shvedova, T., Lerner, A., Kudar, P., Kopteva, O., Petrachkova, D., Koroleva, I., Leontieva, G., Ponkratov, S., & Suvorov, A. (2024). Exploring immune response and lab markers across COVID‑19 severity levels. AIMS Allergy and Immunology, 8(4), 216–231.

Exploring Immune Response and Lab Markers Across COVID-19 Severity Levels

Productos recomendados: Recombinant SARS-CoV-2 N Protein N-His comprado en abinScience
Pomelova, Vera & Bychenkova, TA & Bekman, NI & Osin, NS & Ishkov, YuN & Styazhkin, KK. (2022). Dynamics of humoral immunity to SARS-CoV-2 in the professionally homogeneous group of people over a two-year period of COVID-19 outbreak. Medicine of Extreme Situations. 10.47183/mes.2022.020.

Dynamics of humoral immunity to SARS-CoV-2 in the professionally homogeneous group of people over a two-year period of COVID-19 outbreak

Productos recomendados: Recombinant SARS-CoV-2 RBD Protein C-His comprado en abinScience
Yang, Y., Deng, Y., Huang, B., Song, Q., Wang, W., Yang, Y.,... & Tan, W. (2022). DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice. Frontiers in Immunology, 13, 827605.

DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice

Productos recomendados: Recombinant SARS-CoV-2 S Protein & E Protein & M Protein C-His comprado en abinScience
He, H., Zhang, Y., Xu, J., Li, Y., Fang, H., Liu, Y., Zhang, S., … (2022). Discovery of orally bioavailable SOS1 inhibitors for suppressing KRAS‑driven carcinoma. Journal of Medicinal Chemistry, 65(19), 13158–13171.

Discovery of Orally Bioavailable SOS1 Inhibitors for Suppressing KRAS-Driven Carcinoma

Productos recomendados: Recombinant Human KRAS/K-Ras 2 (G12C) Protein N-GST comprado en abinScience
Li, J., Shi, J., Zhou, Z., Yang, B., Cao, J., Cao, Z.,... & Hu, Z. (2023). Development of an Antigen Detection Kit Capable of Discriminating the Omicron Mutants of SARS-CoV-2. Vaccines, 11(2), 303.

Development of an Antigen Detection Kit Capable of Discriminating the Omicron Mutants of SARS-CoV-2

Productos recomendados: Recombinant SARS-CoV-2 N Protein N-His comprado en abinScience
Zhang, L., Li, K., Gong, J., Gong, J., Li, D., Wang, J.,... & Li, J. (2025). Development and application of highly sensitive protein sensor based on spatial conformation of sodium alginate gel-stabilized HE4. Microchemical Journal, 213, 113863.

Development and Application of Highly Sensitive Protein Sensor Based on Spatial Conformation of Sodium Alginate Gel- Stabilized HE4

Productos recomendados: HE4 comprado en abinScience
He, H., Chen, R., Wang, Z., Li, Y., Gauthier, M., Zhang, S.,... & Fang, H. (2023). Design of Orally-bioavailable Tetra-cyclic phthalazine SOS1 inhibitors with high selectivity against EGFR. Bioorganic Chemistry, 136, 106536.

Design of Orally-bioavailable Tetra-cyclic phthalazine SOS1 inhibitors with high selectivity against EGFR

Productos recomendados: Recombinant Human KRAS/K-Ras 2 (G12C) Protein comprado en abinScience
He, H., Zhang, Y., Xu, J., Liu, Y., Wang, Z., Li, Y.,... & Zhang, S. (2022). Design and Structural Optimization of Orally Bioavailable SOS1 Inhibitors for the Treatment of KRAS-Driven Carcinoma. Journal of Medicinal Chemistry, 65(23), 16001-16016.

Design and Structural Optimization of Orally Bioavailable SOS1 Inhibitors for the Treatment of KRAS-Driven Carcinoma

Productos recomendados: Recombinant Human KRAS/K-Ras 2 (G12C) Protein comprado en abinScience

Obtener una cotización gratuita